Experts highlight how adrenal disorders such as Conn’s syndrome and Cushing’s syndrome can silently damage the kidneys.

A steroid hormone called aldosterone is linked to an increased risk of kidney failure in patients with chronic kidney disease (CKD), according to a study published in the European Heart Journal today ...

A steroid hormone called aldosterone is linked to an increased risk of kidney failure in patients with chronic kidney disease (CKD), according to a study published in the European Heart Journal [1] ...

A drug that has been used to slow progression of kidney and cardiovascular disease in people with type 2 diabetes may also help people with chronic kidney disease who do not have diabetes, according ...

Raised blood pressure remains the leading modifiable risk factor for cardiovascular disease and premature mortality worldwide ...

Please provide your email address to receive an email when new articles are posted on . Half of participants experienced a clinically meaningful decrease in albuminuria after taking BI 690517. Of ...

A new study from researchers at Brigham and Women’s Hospital suggests that a hormone called aldosterone may play a much larger role in high blood pressure than doctors previously believed. This ...

In the previous issue of the Journal, Mulè et al. 1 report the results of a cross-sectional study aimed at assessing (1) plasma aldosterone concentrations and left ventricular mass (LVM) in essential ...

Credit: Getty Images Investigators report promising results from a phase 2 trial of an investigational aldosterone synthase inhibitor. Combining the aldosterone synthase inhibitor with empagliflozin ...

Please provide your email address to receive an email when new articles are posted on . Mineralocorticoid receptor antagonists, particularly the most recently approved agent finerenone, should play a ...

In a phase 2 trial, an investigational drug that inhibits aldosterone synthase significantly lowered albuminuria in patients with or without type 2 diabetes. PHILADELPHIA—A novel selective aldosterone ...